Blocking or depleting TIGIT in HBsAg-transgenic mice with an adaptive immune system that is tolerant of HBsAg led to the breakdown of adaptive immune tolerance, followed by persistent hepatic inflammation, and eventually HCC development that was dependent on CD8+ T cells [35]. Here, TIGIT is linked to hepatocellular carcinoma.